other names for retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the What is the studied dose

Research shows that up to 40% of weight lost during GLP-1 treatment can come from fat-free mass, including muscle

doi: 10.1124/PR.115.011395 2 DruckerDJ

Who Is Not a Good Candidate for Ozempic for Weight Loss

My start-up is developing what would ultimately be a drug thats not only complementary to a GLP-1, but could potentially replace it and could also be used in a maintenance setting. He predicts that once there is a better understanding of different combination therapies with other mechanisms that can complement or replace GLP-1 for more effective weight loss, food technology and nutrition will play an even larger role

The Lancet: Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 randomized trial

Thyroid Cancer: Similar to other GLP-1 drugs, exenatide may have a potential risk for thyroid cancer (particularly medullary thyroid carcinoma), though this has not been definitively proven in humans